If you have been reading about IGF-1 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
=== Re–Ru === Lynne Regan (Ph.D. 1987). British biochemist and biotechnologist at the University of Edinburgh which studies interactions between proteins and nucleic acids. Jens Reich (b. 1939). German biophysicist at the Central Institute of Molecular Biology of the Academy of Sciences in Berlin-Buch, pioneer in systems biology. Founder of the New Forum (civil rights movement). Jacques Ricard (1929–2018). French biochemist at the Institut Jacques Monod known for studies of plant enzymes and for developing the concept of enzyme memory. David Rittenberg (1906–1970). American biochemist at Columbia, a pioneer in the use of radioactive tracers to study metabolism. Member Natl. Acad. Sci. USA. Alexander Rich (1924–2015). American biophysicist at MIT, whose many contributions included elucidation of the structure of collagen (with Francis Crick). Member Natl. Acad. Sci. USA. Jane S. Richardson (b. 1941). American biophysicist at Duke University, known for the ribbon diagram, a method of representing the 3D structures of proteins. Member Natl. Acad. Sci. USA. Thorburn Brailsford Robertson (1884–1930), Australian physiologist and biochemist, known for promoting the use of insulin for diabetes in Australia. Dame Carol V. Robinson (b. 1956), British chemist and mass spectroscopist at the University of Oxford known for studies of protein folding. Robert G. Roeder (b. 1942), American biochemist, pioneer in eukaryotic transcription. Irwin Rose (1926–2015). American biochemist at the University of Pennsylvania, noted for the discovery of ubiquitin-mediated protein degradation.
== See also == Ancient DNA Biocultural anthropology Biological distance analysis Odontometrics Osteoarchaeology Paleopathology Zooarchaeology 2025 in bioarchaeology 2026 in bioarchaeology Dental analysis in archaeology
In the United States, an El Niño is declared when the Climate Prediction Center, which monitors the sea surface temperatures in the Niño 3.4 region and the tropical Pacific, forecasts that the sea surface temperature will be .5 °C (0.90 °F) above average or more for the next several seasons. The Niño 3.4 region stretches from the 120th to 170th meridians west longitude astride the equator five degrees of latitude on either side, are monitored. It is approximately 3,000 kilometres (1,900 mi) to the southeast of Hawaii. The most recent three-month average for the area is computed, and if the region is more than 0.5 °C (0.9 °F) above (or below) normal for that period, then an El Niño (or La Niña) is considered in progress. In February 2026, anomalous increases in tropical sea surface temperatures caused NOAA to revise the threshold distinguishing La Niña and El Niño from each other. The new method replaces a dependency on a 30-year climate base period with the Relative Oceanic Niño Index (RONI): a comparison of the ENSO region to the global tropics. The Australian Bureau of Meteorology looks at the trade winds, Southern Oscillation Index, weather models and sea surface temperatures in the Niño 3 and 3.4 regions, before declaring an ENSO event. The Japan Meteorological Agency declares that an ENSO event has started when the average five month sea surface temperature deviation for the Niño 3 region is over 0.5 °C (0.90 °F) for six consecutive months or longer.
Luminescence dating methods are not radiometric dating methods in that they do not rely on abundances of isotopes to calculate age. Instead, they are a consequence of background radiation on certain minerals. Over time, ionizing radiation is absorbed by mineral grains in sediments and archaeological materials such as quartz and potassium feldspar. The radiation causes charge to remain within the grains in structurally unstable "electron traps". Exposure to sunlight or heat releases these charges, effectively "bleaching" the sample and resetting the clock to zero. The trapped charge accumulates over time at a rate determined by the amount of background radiation at the location where the sample was buried. Stimulating these mineral grains using either light (optically stimulated luminescence or infrared stimulated luminescence dating) or heat (thermoluminescence dating) causes a luminescence signal to be emitted as the stored unstable electron energy is released, the intensity of which varies depending on the amount of radiation absorbed during burial and specific properties of the mineral. These methods can be used to date the age of a sediment layer, as layers deposited on top would prevent the grains from being "bleached" and reset by sunlight. Pottery shards can be dated to the last time they experienced significant heat, generally when they were fired in a kiln.
=== Music === V.I.P. (Hungarian band), a defunct pop boy group The V.I.P.'s (band), an English band of the 1960s Voices in Public, a Canadian boy group VVIP (hip-hop group), a Ghanaian hiplife band, formerly known as VIP (or Vision In Progress) V.I.P. (album), a 2000 album by Jungle Brothers, or the title track "V.I.P." (Bro'Sis song) (2003) "V.I.P" (Ice Prince song) (2013) "V.I.P" (Sid song) (2013) "VIP" (Aya Nakamura song) (2022) V.I.P., a subsidiary label of Motown Records VIP Music Records, an American record label based in New York City (founded 2004) VIP Records, a record store chain from Los Angeles, California (founded 1967) "VIP", a song by Kesha from Animal (Kesha album) The V.I.P. (The Vanilla Ice Posse), the rapper's DJs and backup dancers Victory in Praise Music and Arts Seminar Mass Choir, an organization founded by John P. Kee "V.I.P.", a song by Françoise Hardy "V.I.P.", a song by R. Kelly from R. (R. Kelly album) V.V.I.P, a 2011 EP by Seungri V.I.P. – Very Important Pony, 2025 EP by HorsegiirL
Sources: en.wikipedia.org
== Organizational structure == The Commission consists of the chairman and other members appointed by the President of the Republic of India. Usually, the Commission consists of 9 to 11 members, including the chairman. Every member holds office for a term of six years or until he attains the age of sixty-five years, whichever is earlier. The terms and conditions of service of the chairman and members of the commission are governed by the Union Public Service Commission (Members) Regulations, 1969. The chairman and any other member of the commission can submit their resignation at any time to the President of India. They may be removed from their office by the President of India on the ground of misbehavior (only if an inquiry of such misbehavior is made and upheld by the Supreme Court) or if he is adjudged insolvent, or engages during the term of office in any paid employment outside the duties of their office, or in the opinion of the president unfit to continue in office because of the infirmity of mind or body.
A carbon-based device called a light-emitting electrochemical cell (LEC) was demonstrated with chemically-derived graphene as the cathode and the conductive polymer Poly(3,4-ethylenedioxythiophene) (PEDOT) as the anode. Unlike its predecessors, this device contains only carbon-based electrodes, with no metal. In 2014 a prototype graphene-based flexible display was demonstrated. In 2016 researchers demonstrated a display that used interferometry modulation to control colors, dubbed a "graphene balloon device" made of silicon containing 10 μm circular cavities covered by two graphene sheets. The degree of curvature of the sheets above each cavity defines the color emitted. The device exploits the phenomena known as Newton's rings created by interference between light waves bouncing off the bottom of the cavity and the (transparent) material. Increasing the distance between the silicon and the membrane increased the wavelength of the light. The approach is used in colored e-reader displays and smartwatches, such as the Qualcomm Toq. They use silicon materials instead of graphene. Graphene reduces power requirements.
== Soluble TCR == A soluble TCR is a TCR that has been made water-soluble using protein engineering. Such a protein is based on changing an existing TCR's chains to remove the transmembrane portions, leaving only the extracellular part. A number of techniques from protein engineering are then used to stabilize the complex and improve its binding characteristics. A soluble TCR can be used as an antigen-binding module, much like how monoclonal antibodies are used in medicine. Their advantage over antibodies is that they make use of the MHC/HLA display mechanism, allowing them to detect not only extracellular antigens, but also fragments of intracellular ones. On the other hand, they also face some restrictions in terms of applicable HLA genotypes due to them being made to target the complex of a MHC protein with the antigen fragment. One idea for overcoming this restriction is to instead target monomorphic HLA-like molecules such as HLA-E, MHC-related protein 1 (MR1) and cluster of differentiation 1 a, b, c and d (CD1a, CD1b, CD1c or CD1d). An example of a protein derived from soluble TCR is tebentafusp, approved by the US FDA in 2022. This designed protein contains a soluble TCR (αβ) targeting a fragment of gp100 presented by HLA-A*02:01 connected to a ScFv that binds CD3. As a result it causes T cells to activate in the vicinity of cells that present gp100, acting as a molecular glue (a bi-specific T-cell engager in the broad sense). It is only applicable to people with the HLA-A*02:01 genotype.
727.6 Rupture of tendon, nontraumatic 727.62 Rupture, biceps tendon 727.67 Rupture, achilles tendon 727.8 Other disorders of synovium, tendon, and bursa 727.83 Plica syndrome 727.89 Abscess, bursa 728 Disorders of muscle, ligament, and fascia 728.0 Infective myositis 728.1 Muscular calcification and ossification 728.2 Muscular wasting, atrophy 728.3 Other specific muscle disorders 728.4 Laxity of ligament 728.5 Hypermobility syndrome 728.6 Dupuytren's contracture 728.7 Other fibromatoses 728.71 Plantar fasciitis 728.8 Other disorders of muscle, ligament, and fascia 728.84 Diastasis recti 728.85 Muscle spasm 728.86 Necrotizing fasciitis 728.87 Muscle weakness 728.88 Rhabdomyolysis 728.89 Iliotibial band syndrome 729 Other disorders of soft tissues 729.0 Rheumatism unspecified and fibrositis 729.1 Myalgia and myositis, Fibromyositis 729.2 Neuralgia neuritis and radiculitis unspecified 729.3 Panniculitis unspecified 729.4 Fasciitis unspecified 729.5 Pain in limb 729.6 Foreign body in soft tissue 729.7 Nontraumatic compartment syndrome
Sources: en.wikipedia.org
Prince August Wilhelm Heinrich Günther Viktor of Prussia (29 January 1887 – 25 March 1949), nicknamed "Auwi", was the fourth son of German Emperor Wilhelm II by his first wife, Augusta Victoria of Schleswig-Holstein. A vocal supporter of Nazism and of Adolf Hitler, he joined the Nazi party in 1930 and rose to the rank of SA-Obergruppenführer.
Sulfur, also spelled as sulphur, is a chemical element; it has symbol S and atomic number 16. It is abundant, multivalent and nonmetallic. Under normal conditions, sulfur atoms form cyclic octatomic molecules with the chemical formula S8. Elemental sulfur is a bright yellow, crystalline solid at room temperature. Sulfur is the tenth most abundant element by mass in the universe and the fifth most common on Earth. Though sometimes found in pure, native form, sulfur on Earth usually occurs as sulfide and sulfate minerals. Being abundant in native form, sulfur was known in ancient times, being mentioned for its uses in ancient India, ancient Greece, China, and ancient Egypt. Historically and in literature sulfur is also called brimstone, which means "burning stone". Almost all elemental sulfur is produced as a byproduct of removing sulfur-containing contaminants from natural gas and petroleum. The greatest commercial use of the element is the production of sulfuric acid for sulfate and phosphate fertilizers, and other chemical processes. Sulfur is used in matches, insecticides, and fungicides. Many sulfur compounds are odoriferous, and the smells of odorized natural gas, skunk scent, bad breath, grapefruit, and garlic are due to organosulfur compounds. Hydrogen sulfide gives the characteristic odor to rotting eggs and other biological processes. Sulfur is an essential element for all life, almost always in the form of organosulfur compounds or metal sulfides.
Six days after the attacks, President Bush made a public appearance at Washington, D.C.'s largest Islamic Center where he acknowledged the "incredibly valuable contribution" of American Muslims and called for them "to be treated with respect." Numerous incidents of harassment and hate crimes against Muslims and South Asians were reported in the days following the attacks. Sikhs were also targeted due to their use of turbans, which are stereotypically associated with Muslims. There were reports of attacks on mosques and other religious buildings (including the firebombing of a Hindu temple), and assaults on individuals, including one murder: Balbir Singh Sodhi, a Sikh mistaken for a Muslim, who was fatally shot on September 15, 2001, in Mesa, Arizona. Two dozen members of Osama bin Laden's family were urgently evacuated out of the country on a private charter plane under FBI supervision three days after the attacks. According to an academic study, people perceived to be Middle Eastern were as likely to be victims of hate crimes as followers of Islam during this time. The study also found a similar increase in hate crimes against people who may have been perceived as Muslims, Arabs, and others thought to be of Middle Eastern origin. A report by the South Asian American advocacy group South Asian Americans Leading Together documented media coverage of 645 bias incidents against Americans of South Asian or Middle Eastern descent between September 11 and 17, 2001. Crimes such as vandalism, arson, assault, shootings, harassment, and threats in numerous places were documented.
The advantages of genetic adjuvants are their low cost and simple administration, as well as avoidance of unstable recombinant cytokines and potentially toxic, "conventional" adjuvants (such as alum, calcium phosphate, monophosphoryl lipid A, cholera toxin, cationic and mannan-coated liposomes, QS21, carboxymethyl cellulose and ubenimex). However, the potential toxicity of prolonged cytokine expression is not established. In many commercially important animal species, cytokine genes have not been identified and isolated. In addition, various plasmid-encoded cytokines modulate the immune system differently according to the delivery time. For example, some cytokine plasmid DNAs are best delivered after immunogen pDNA, because pre- or co-delivery can decrease specific responses and increase non-specific responses.
== References == This article was adapted from the following source under a CC BY 4.0 license (2018) (reviewer reports): Cody J Hall; Tatiana P. Soares da Costa (2018). "Lysine: biosynthesis, catabolism and roles" (PDF). WikiJournal of Science. 1 (1): 4. doi:10.15347/wjs/2018.004. Wikidata Q55120301.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.